Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 4, 2025 • 11:31 PM ET

Date/Time Source News Release
07/10/2025 08:00 AM EDT GlobeNewswire Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference
06/05/2025 08:00 AM EDT GlobeNewswire Cocrystal Pharma's Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
05/29/2025 08:00 AM EDT GlobeNewswire Cocrystal Pharma's Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain
05/28/2025 08:00 AM EDT GlobeNewswire Cocrystal Pharma to Participate in Noble Capital Markets' 2025 Emerging Growth Virtual Equity Conference
05/15/2025 08:00 AM EDT GlobeNewswire Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
04/24/2025 08:00 AM EDT GlobeNewswire Cocrystal Pharma's Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
04/16/2025 08:00 AM EDT GlobeNewswire Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
03/31/2025 08:00 AM EDT GlobeNewswire Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
03/14/2025 08:35 AM EDT GlobeNewswire Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
03/12/2025 01:12 PM EDT GlobeNewswire Life Sciences Investor Forum Agenda Announced for March 13th
Page

Additional News

As of August 4, 2025 • 11:31 PM ET

Date/Time Source News Release
05/15/2025 08:21 AM EDT SeekingAlpha Cocrystal Pharma GAAP EPS of -$0.23
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:30 AM EDT US Earnings Reports Expected earnings - Cocrystal Pharma Inc.
03/31/2025 08:13 AM EDT SeekingAlpha Cocrystal Pharma GAAP EPS of -$1.72
03/27/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 27th, 2025
03/27/2025 05:30 AM EDT US Earnings Reports Expected earnings - Cocrystal Pharma Inc.
03/12/2025 04:15 PM EDT Investing News Network Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines
12/31/2024 11:50 AM EST SeekingAlpha Cocrystal stock plunges 40% on influenza drug update
12/30/2024 11:07 AM EST InvestorBrandNetwork Cocrystal Pharma Inc. (NASDAQ: COCP) Sets New 52-Week High in Monday Session
11/13/2024 08:13 AM EST SeekingAlpha Cocrystal Pharma GAAP EPS of -$0.49 beats by $0.08
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.